<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911024-0129</DOCNO><DOCID>911024-0129.</DOCID><HL>   Who's News:   Oncor Inc.</HL><DATE>10/24/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B11</SO><CO>   ONCR WNEWS</CO><MS>TECHNOLOGY (TEC)</MS><IN>MEDICAL andamp; BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><NS>PERSONNEL ANNOUNCEMENTS, PROMOTIONS, APPOINTMENTS (PER)</NS><RE>MARYLAND (MD)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   ONCOR Inc. (Gaithersburg, Md.) -- George E. Evanega, 55,was named president and chief operating officer at this makerand marketer of DNA probes for cancer and genetic diseasedetection. Dr. Evanega, who succeeds Stephen Turner, 46, aspresident, had been corporate vice president and chiefadministrative officer of Miles Inc., a health caresubsidiary of Bayer USA Inc., which in turn, is controlled byBayer AG of Germany. Mr. Turner will continue as chairman andchief executive.</LP><TEXT/></DOC>